Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
6 Mar, 2024 (Wednesday)

            
EVEREST MED(1952)
Analysis:
Everest Medicines (1952) is transforming from a clinical stage biotech company into a global biopharma company with comprehensive and fully integrated capabilities, including drug discovery, clinical development, manufacturing and commercialization. It has built a portfolio across its core therapeutic areas: renal diseases, infectious diseases and autoimmune disorders. In July 2023, its first product, Xerava, was successfully launched in China for the treatment of complicated intra-abdominal infections (“cIAI”) in adult patients. According to its recent business update, the Group is expected to record a total revenue ranging between approximately RMB124 million and approximately RMB126 million for the year ended 31 December 2023, as compared to a total revenue of approximately RMB12.8 million for the year ended 31 December 2022. The substantial increase in total revenue of the Group for the year ended 31 December 2023 was mainly due to the successful launch of Xerava in China as well as the launch of Nefecon in Macau in December 2023. Following the commercial launch of Xerava, it has three drug candidates in line to receive NDA approvals or file NDAs in 2024. (I do not hold the above stock)
Strategy:
Buy-in Price: $22.50, Target Price: $25.00, Cut Loss Price: $21.40


TIME INTERCON(1729)
Analysis:
During the six months ended 30 September 2023, Time Interconnect Technology (01729) recorded revenue amounting to HK$2,627 million, represented a decrease of 19.9% as compared for the same period of 2022. The decrease was mainly attributable to the decrease of revenue from server business and digital cable business. Operating profit for the reporting period was HK$235 million, represented a significant increase of 82.8%, as compared for the same period of 2022, with the operating profit margin raised from 3.9% to 9.0%. The increase of operating profit was mainly attributable to the profitability improvement of server business. Last year, the company expanded its business to server business with go-to-market strategy and JDM/ODM business model. The server business is deeply customised according to brand customers` requirements and the products offered by the company under the server business are mainly applied in data centres. The server business and the existing wire and cable business have an upstream and downstream relationship, so it represents an opportunity for the company to expand its existing converged wire and cable products to a larger customer portfolio. In addition to contributing a substantial increase in revenue, the server business also contributed a significant increase in profits this year by adjusting its customer/product portfolio and selling price structure to improve profitability. The PRC has continuously made great efforts to accelerate the research and development of 5G technology. As more and more 5G devices and equipment will be gradually and massively replaced in the coming years, it is expected to drive the demand of cable assembly products and telecommunication sector and benefit the company's business growth. Moreover, in cloud computing, the computing storage network must be placed in the data centre, therefore, the growing cloud technology is expected to drive the development of data centre. Thus, it is very positive on the continuous growth of the business of data centre sector.
Strategy:
Buy-in Price: $1.56, Target Price: $1.74, Cut Loss Price: $1.46



Cathay Pacific (293.HK) - Favorable Business Indicators and Constant Financial Improve

Investment Summary

Performance Rebounds Strongly in the First Half of 2023 with Second Highest Net Profit of HK$4.3 Billion

Acoording to Cathay Pacific Airways Limited ("Cathay Pacific" or the "Company") FY2023H result: the Company recorded revenue of HK$43,593 million, up by 135% yoy, which recovered to 81.4% of that in the same period of 2019 (specifically, passenger revenue and cargo revenue recovered to 73.6% and 108% of those in the same period of 2019, respectively). Operating costs stood at HK$36,957 million, accounting for 72.4% of that in the first half of 2019. The attributable profit amounted to HK$4,268 million, which significantly made good a deficit (the loss in the same period of 2022 was HK$4,999 million), and was substantially greater than the figure of HK$1,347 million in the first half of 2019. The corresponding basic earnings per share were approximately HK61.5 cents.

Specifically, a portion of the attributable profit came from a one-off non-cash gain of HK$1.9 billion recognized in the current period: Air China completed A-share seasoned equity offering in January 2023, thus diluting the shareholding of Cathay Pacific in Air China (down from 18.13% to 16.26%), which was regarded as a sale of some shares in Air China..

Favorable Business Indicators and Constant Financial Improve

The passenger load factor of Cathay Pacific in the Reporting Period jumped by 28 percentage points yoy to 87.2%, higher than the figure of 84.2% in the same period before the pandemic (i.e. the first half of 2019, the same below), as driven by the increase in transfer passengers after the resumption of normal traveler clearance between Hong Kong and the Chinese Mainland as well as the surge in demand of flights to Europe and America. Due to the growth of transport capacity, ticket rates fell from the historic high. Meanwhile, the passenger yield declined by 32% yoy to HK77.4 cents, which still greatly exceeded that of HK54.9 cents in the same period before the pandemic. However, the cargo load factor and the cargo yield decreased, as the boom in the pandemic period waned, by 12 percentage points and 51.7% yoy to 63.8% and HK$2.76, respectively, which were 0.4 percentage points and HK$0.88 higher than the pre-pandemic levels.

Fuel Costs Allow Rate Cuts, Burdens from Associates Will Decrease

With respect to costs, the Company's net fuel costs leaped by 304% yoy to HK$10,635 million, accounting for 72% of the pre-pandemic level, because of the growth in fuel consumption of HK$6.5 billion following the work resumption of many planes and the year-on-year decrease of fuel hedging gains of HK$1.51 billion. Nevertheless, unit costs were largely diluted due to the rising business volume. The cost per ton-kilometer (including fuel)fell from HK$5.88 to HK$3.35, which was HK$3.12 before the pandemic. Additionally, the cost per ton-kilometer less fuel decreased from HK$5.19 to HK$2.34, which was HK$2.23 before the pandemic. As of December 11, the trading price of Brent crude oil futures was approximately US$75.67 per barrel, dropping by more than 20% from the peak value of approximately US$97 per barrel in September. We expect fuel costs will continue to decrease.

Cathay Pacific has maintained positive operating cash flow since the beginning of 2023. Moreover, it has redeemed 50% of preference shares recently, and plans to redeem the rest 50% by the end of July 2024. Then, the Company will hopefully restore dividend distribution.

The Company recorded the attributable losses of associates of HK$2.62 billion in the first half of the year, mainly because of Air China's loss of RMB13.4 billion in the accounting period. Fortunately, the Company's burden from associates will significantly decrease, since Air China turned losses into profits of RMB3.72 billion in the second half of the year.

Investment thesis

As of the end of June 2023, the Company had 225 planes, including 35 cargo aircraft (including rented ones). Furthermore, Cathay Pacific has recently announced its plan to purchase 32 passenger aircraft and six cargo aircraft, which will be conducive to expanding outlets and strengthening efficiency. The Company has gotten back on track, after the three-year hardship of the pandemic, and, driven by both demand and supply, will further regain its profitability.

At present, the corresponding price-to-book ratio of the stock price is less than 0.8 times, which is the lowest point in the past 20 years.

Based on the revised financial forecast, we lift target price to HK$10 for the Company, equivalent to 2023/2024/2025E 0.98/0.92/0.84 x P/B, reaffirming the buy rating. (Closing price as at 23 February)

Risk

Surging oil price

RMB depreciation

Demand affected by economy

Transformation program failed

Financials

Click Here for PDF format...




Recommendation on 6-3-2024
RecommendationBuy
Price on Recommendation Date$ 8.150
Suggested purchase priceN/A
Target Price$ 10.000
Writer Info
Zhang Jing
(Research Analyst)
Tel: (+86 21 51699400-103)
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2024 Phillip Securities (HK) Ltd. All Rights Reserved.